Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1510
+0.0290 (23.77%)
Jun 1, 2026, 3:58 PM HKT

HKG:8189 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
322651616169379322
Market Cap Growth
-67.87%5.71%265.17%-55.50%17.65%73.47%
Enterprise Value
401575945219415295
Last Close Price
0.150.300.330.090.200.17
PS Ratio
0.551.121.500.390.830.55
PB Ratio
105.98214.0720.342.374.132.38
P/TBV Ratio
23.6947.8526.123.065.782.60
EV/Sales Ratio
0.690.992.300.500.910.51
Debt / Equity Ratio
40.1740.175.701.331.260.82
Net Debt / Equity Ratio
29.4829.484.811.241.180.57
Net Debt / EBITDA Ratio
-1.33-1.33-6.39-7.64-6.44-4.41
Net Debt / FCF Ratio
---4.74-5.11-4.41-1.83
Asset Turnover
1.751.751.211.241.181.29
Inventory Turnover
5.085.084.454.585.215.16
Quick Ratio
0.190.190.140.110.210.35
Current Ratio
0.750.750.840.880.891.09
Return on Equity (ROE)
-728.50%-728.50%-81.67%-15.05%-24.59%-33.73%
Return on Assets (ROA)
-14.16%-14.16%-5.58%-3.77%-4.46%-3.10%
Return on Invested Capital (ROIC)
-81.28%-54.48%-18.34%-12.05%-13.96%-10.58%
Return on Capital Employed (ROCE)
-520.20%-520.20%-53.10%-22.40%-20.50%-11.80%
Earnings Yield
-31.37%-15.53%-4.81%-13.17%-8.19%-16.11%
FCF Yield
-21.70%--4.98%-10.21%-6.45%-13.07%
Buyback Yield / Dilution
-9.77%-9.77%----